Automated Molecular Diagnostics Testing System Market

Automated Molecular Diagnostics Testing System Market contains market size and forecasts of Automated Molecular Diagnostics Testing System in global, including the following market information:

• Global Automated Molecular Diagnostics Testing System Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global Automated Molecular Diagnostics Testing System Market Sales, 2018-2023, 2023-2030, (K Units)
• Global top five Automated Molecular Diagnostics Testing System companies in 2022 (%)

The global Automated Molecular Diagnostics Testing System market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

PCR (Polymerase Chain Reaction) Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Automated Molecular Diagnostics Testing System include Roche Holding AG, Abbott Laboratories, Becton Dickenson & Company, Siemens Healthcare GmbH, Enigma Diagnostics Ltd, Qiagen, Bio-Rad Laboratories, Cepheid Inc. and PerkinElmer Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Automated Molecular Diagnostics Testing System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Automated Molecular Diagnostics Testing System Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)

Global Automated Molecular Diagnostics Testing System Market Segment Percentages, by Type, 2022 (%)

• PCR (Polymerase Chain Reaction)
• FISH (Fluorescent In-situ Hybridization)
• Spectral Karyotype Imaging
• DNA Microarrays

Global Automated Molecular Diagnostics Testing System Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)

Global Automated Molecular Diagnostics Testing System Market Segment Percentages, by Application, 2022 (%)

• Pathology Laboratories
• Hospitals
• Research Centers
• Academic Institutions
• Commercial R&D Centers

Global Automated Molecular Diagnostics Testing System Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)

Global Automated Molecular Diagnostics Testing System Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Automated Molecular Diagnostics Testing System revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Automated Molecular Diagnostics Testing System revenues share in global market, 2022 (%)
• Key companies Automated Molecular Diagnostics Testing System sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Automated Molecular Diagnostics Testing System sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Holding AG
• Abbott Laboratories
• Becton Dickenson & Company
• Siemens Healthcare GmbH
• Enigma Diagnostics Ltd
• Qiagen
• Bio-Rad Laboratories
• Cepheid Inc.
• PerkinElmer Inc.
• AutoGenomics
• ELITech Group